12 July 2022

IAM Patent 1000 Rankings

Congratulations to our IP Transactions Group for being ranked in the 2022 IAM Patent 1000 Rankings!

Congratulations to our IP Transactions Group for being ranked in the 2022 IAM Patent 1000 Rankings!


19 November 2021
Advs. Daniel Green and Tali Har-Oz represented Oravax Medical, a joint venture established by Oramed Pharmaceuticals and Premas Biotech, in a strategic collaboration agreement with Genomma Lab Internacional whereby Genomma Lab would develop and commercialize Oravax’s oral COVID-19 vaccine in Mexico and drive business development in Latin America.

Advs. Daniel Green and Tali Har-Oz represented Oravax Medical, a joint venture established by Oramed Pharmaceuticals and Premas Biotech, in a strategic collaboration agreement with Genomma Lab Internacional whereby Genomma Lab would develop and commercialize Oravax’s oral COVID-19 vaccine in Mexico and drive business development in Latin America.


17 December 2019
Advs. Barak Platt, Ezra Gross, Josh Hauser, Ben Sandler, Dr. Eran Lempert, Daniel Green, Ira Evental, Miriam Friedmann, Tali Har-Oz, Sophy Litvin, Nir Kamhi, Ofir Paz, Evan Schendler, and interns Adina Mirchin, Leah Grumet and Noah Levi represented Intel in its $ 2 billion acquisition of Israeli based artificial intelligence chip developer Habana Labs.

Advs. Barak Platt, Ezra Gross, Josh Hauser, Ben Sandler, Dr. Eran Lempert, Daniel Green, Ira Evental, Miriam Friedmann, Tali Har-Oz, Sophy Litvin, Nir Kamhi, Ofir Paz, Evan Schendler, and interns Adina Mirchin, Leah Grumet and Noah Levi represented Intel in its $ 2 billion acquisition of Israeli based artificial intelligence chip developer Habana Labs.


28 May 2019
Barak Platt and Josh Hauser represented Intel Capital in leading a $17 million Series A investment in SWIR (short-wave-infra-red) sensing technology developer TriEye.

Barak Platt and Josh Hauser represented Intel Capital in leading a $17 million Series A investment in SWIR (short-wave-infra-red) sensing technology developer TriEye.

VentureBeat.com

Subscribe for updates and news